131 related articles for article (PubMed ID: 35536073)
1. Analytical Performance Evaluation of Goldstream Fungus (1-3)-β-D Glucan.
So MK; Huh J; Lee M; Kim SK
Clin Lab; 2022 May; 68(5):. PubMed ID: 35536073
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
Song J; Kim S; Park J; Park Y; Kim HS
Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115415. PubMed ID: 34082306
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Performance of the Associates of Cape Cod STAT Assay for the Diagnosis of Invasive Fungal Disease in Critical-Care Patients with COVID-19.
White PL; Price JS; Backx M
J Clin Microbiol; 2021 Aug; 59(9):e0086921. PubMed ID: 34190576
[TBL] [Abstract][Full Text] [Related]
4. Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β-d-Glucan Assay.
Skubic J; Taghavi S; Castillo-Angeles M; Ramsis R; Salim A; Askari R
Surg Infect (Larchmt); 2020 Jun; 21(5):461-464. PubMed ID: 31895667
[No Abstract] [Full Text] [Related]
5. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
6. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
[TBL] [Abstract][Full Text] [Related]
7. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
8. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Performance of the Dynamiker Fungus (1-3)-β-D-Glucan and Fungitell Assay for Diagnosis of Candidemia: Need for New Cut-off Development and Test Validation.
Yazdanpanah S; Rahbarmah M; Motamedi M; Khodadadi H
Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116118. PubMed ID: 37992564
[TBL] [Abstract][Full Text] [Related]
10. Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F; Nucci M; Fernandez-Cruz A; Azoulay E; Lanternier F; Bremerich J; Einsele H; Johnson E; Lehrnbecher T; Mercier T; Porto L; Verweij PE; White L; Maertens J; Alanio A;
Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37381179
[TBL] [Abstract][Full Text] [Related]
11. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.
Cornu M; Goudjil S; Kongolo G; Leke A; Poulain D; Chouaki T; Sendid B
Med Mycol; 2018 Jan; 56(1):78-87. PubMed ID: 28371838
[TBL] [Abstract][Full Text] [Related]
13. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.
Calitri C; Caviglia I; Cangemi G; Furfaro E; Bandettini R; Fioredda F; Amoroso L; Faraci M; Risso FM; Mattioli G; Moscatelli A; Haupt R; Castagnola E
Mycoses; 2017 Dec; 60(12):789-795. PubMed ID: 28833726
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
[TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of Fungitell STAT™, a rapid (1→3)-β-D-glucan single patient sample in vitro diagnostic assay.
D'Ordine RL; Garcia KA; Roy J; Zhang Y; Markley B; Finkelman MA
Med Mycol; 2021 Jan; 59(1):41-49. PubMed ID: 32400855
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults.
Lamoth F; Akan H; Andes D; Cruciani M; Marchetti O; Ostrosky-Zeichner L; Racil Z; Clancy CJ
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S102-S108. PubMed ID: 33709130
[TBL] [Abstract][Full Text] [Related]
18. Glucan rich nutrition does not increase gut translocation of beta-glucan.
Hoenigl M; Lin J; Finkelman M; Zhang Y; Karris MY; Letendre SL; Ellis RJ; Burke L; Richard B; Gaufin T; Isnard S; Routy JP; Gianella S
Mycoses; 2021 Jan; 64(1):24-29. PubMed ID: 32780885
[TBL] [Abstract][Full Text] [Related]
19. UTILITY OF OCULAR β- d -GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.
Xia T; Finkelman M; Kolomeyer A; Ying GS; Bracha P; Miller CG; Elnahry AG; Carroll R; Zhang Y; Saluadades A; Brucker AJ; Kim BJ
Retin Cases Brief Rep; 2023 Nov; 17(6):676-682. PubMed ID: 35199648
[TBL] [Abstract][Full Text] [Related]
20. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
Forster J; Dichtl K; Wagener J
Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
